Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amplifon SpAAMFPF 78 Future 3-5Y EPS without NRI Growth Rate is 35.10 as of Sep. 22, 2026. GuruFocus rates AMFPF with a GF Score™ of 78/100 and a GF Value™ of $22.84. The stock has 6 warning signs investors should review. Among 34 Medical Distribution companies, Amplifon SpA ranks better than 82.35% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, Amplifon SpA's Future 3-5Y EPS without NRI Growth Rate is 35.10.
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Amplifon SpA Future 3-5Y EPS without NRI Growth Rate Related Terms
AMFPF vs MCK, COR, CAH: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Distribution subindustry, Amplifon SpA's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA Future 3-5Y EPS without NRI Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 35.10 mean?
Amplifon SpA (AMFPF) has a Future 3-5Y EPS without NRI Growth Rate of 35.10 as of Sep. 22, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Amplifon SpA and its competitors. According to the industry distribution chart, Amplifon SpA ranks #6 out of 34 companies in the Medical Distribution industry, placing it in the top 17.6%.
Is Amplifon SpA's Future 3-5Y EPS without NRI Growth Rate too high?
Amplifon SpA's current Future 3-5Y EPS without NRI Growth Rate is 35.10. The Medical Distribution industry median Future 3-5Y EPS without NRI Growth Rate is 9.79. Amplifon SpA's value of 35.10 is 258.7% above this industry median. Based on the distribution chart, Amplifon SpA ranks #6 out of 34 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amplifon SpA has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's Future 3-5Y EPS without NRI Growth Rate compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #6 out of 34 companies for Future 3-5Y EPS without NRI Growth Rate. This places Amplifon SpA in the top 18% of its industry — outperforming the majority of peers. The industry median Future 3-5Y EPS without NRI Growth Rate is 9.79. Amplifon SpA's value of 35.10 is 258.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Medical Distribution company?
The median Future 3-5Y EPS without NRI Growth Rate among Medical Distribution companies is 9.79, based on 34 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current Future 3-5Y EPS without NRI Growth Rate of 35.10 is 258.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Amplifon SpA and its competitors. For the Medical Distribution industry, the median Future 3-5Y EPS without NRI Growth Rate is 9.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current Future 3-5Y EPS without NRI Growth Rate is 35.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Amplifon SpA (AMFPF) has a current Future 3-5Y EPS without NRI Growth Rate of 35.10. The stock's GF Value™ is $22.84, compared to a current price of $11.21 — trading 50.9% below its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 35.10 and 258.7% above the Medical Distribution industry median of 9.79. Amplifon SpA's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Amplifon SpA (AMFPF), the current Future 3-5Y EPS without NRI Growth Rate is 35.10 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPF) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $11.21 is trading 50.9% below its estimated GF Value™ of $22.84.
Key valuation signals for AMFPF:
Future 3-5Y EPS without NRI Growth Rate: 35.10
GF Value™: $22.84 vs. price of $11.21 (50.9% below fair value)
Industry Position: 258.7% above the Medical Distribution median (#6 of 34)
No single metric tells the full story. See the AMFPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
78GF Score
Get the complete analysis for AMFPF
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPF has been successfully added to your 
